Biodesix, Inc. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Net Debt Issuance
Cash Flow
Cash Flow by Activity
Operating Cash Flow
$778K
Free Cash Flow↑+182.5% +$2M
$692K
Investing Cash Flow↑+49.8% +$136K
$-137K
Financing Cash Flow
$2M
Capex↓-89.7% -$753K
$86K
Stock-Based Comp↓-15.0% -$190K
$1M
Debt Issued
—
Debt Repaid↓-61.5% -$8K
$5K
D&A↓-4.3% -$62K
$1M
SBC Allocated Expense↓-15.0% -$190K
$1M